APA

Colombel J., Sandborn W. J., Reinisch W., Peyrin-Biroulet L., Panaccione R., Rutgeerts P., Hanauer S. B., Ghosh S., Van Assche G., Robinson A. M., Lau W., Maa J., Huang B., Pappalardo B. & Read H. (20180521). Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. : Alimentary pharmacology & therapeutics.

Chicago

Colombel J-F, Sandborn W J, Reinisch W, Peyrin-Biroulet L, Panaccione R, Rutgeerts P, Hanauer S B, Ghosh S, Van Assche G, Robinson A M, Lau W, Maa J-F, Huang B, Pappalardo B and Read H. 20180521. Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. : Alimentary pharmacology & therapeutics.

Harvard

Colombel J., Sandborn W. J., Reinisch W., Peyrin-Biroulet L., Panaccione R., Rutgeerts P., Hanauer S. B., Ghosh S., Van Assche G., Robinson A. M., Lau W., Maa J., Huang B., Pappalardo B. and Read H. (20180521). Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. : Alimentary pharmacology & therapeutics.

MLA

Colombel J-F, Sandborn W J, Reinisch W, Peyrin-Biroulet L, Panaccione R, Rutgeerts P, Hanauer S B, Ghosh S, Van Assche G, Robinson A M, Lau W, Maa J-F, Huang B, Pappalardo B and Read H. Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. : Alimentary pharmacology & therapeutics. 20180521.